Management and Team
Jean-François Millau, PhD
CEO and co-founder
Kevin Neil, PhD
CSO and co-founder
Véronique Riethuisen, MSc
CFO
Alexandre LeBeaut, MD
CMO
Marie-Eve Poisson
Julie Douchin, PhD
Samuel Jacques, PhD
Guillaume St-Cyr, PhD
Animal technician
Business development and operations manager
Senior scientist
Junior scientist
Board members
Jacques Dessureault, MSc, C.Dir., CCA
Chairman of the board
Jean-François Millau, PhD
CEO TATUM bioscience
Marc Rivière, MD
General Partner and CMO at TVM Capital
Rebecca Allan, PhD
Investment Manager Life Sciences at BoxOne Venture
Jesse Paterson, MSc
Senior Director Business Development at CQDM
Advisors
Medical
Stéphane Champiat, MD PhD
Medical Oncologist in early drug development & Immunotherapy specialist
Howard Kauffman, MD
CEO Ankyra Therapeutics and Oncology Associate
Gerald Batist, MD
Director at Segal Cancer Centre
Business
Pierre Corby, MSc MBA
Healthcare Equity Specialist at UBP
Scientific
Sébastien Rodrigue, PhD
Co-founder and Full Professor at the Université de Sherbrooke
Jamie Scott, MD PhD
Professor Emerita in Molecular Immunology & Vaccinology
Drug Development
François-Xavier Lacasse, PhD
Professor in Pharmaceutical development